Today's Hours: 10:00am - 6:00pm

Search

Did You Mean:

Search Results

  • Book
    Ruth Dennis, Robert M. Kirberger, Frances Barr, Robert H. Wrigley.
    Summary: This book is intended for all users of small animal diagnostic imaging, from radiologists through to general practitioners to veterinary students, and will be an invaluable supplement to existing references in the subject. --Book Jacket.

    Contents:
    Skeletal system : general
    Joints
    Appendicular skeleton
    Head and neck
    Spine
    Lower respiratory tract
    Cardiovascular system
    Other thoracic structures : pleural cavity, mediastinum, thoracic oesophagus, thoracic wall
    Other abdominal structures : abdominal wall, peritoneal and retroperitoneal cavities, parenchymal organs
    Gastrointestinal tract
    Urogenital tract
    Soft tissues.
    Digital Access ScienceDirect 2010
  • Article
    Oppel F, Schulze G.
    Pharmakopsychiatr Neuropsychopharmakol. 1978 Mar;11(2):76-80.
    The influence of prodipin, a putative dopamine releasing compound, on the concentration of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the spinal liquor of 28 patients with Parkinson's disease was investigated. The patients were divided into three groups. In group 1 the combined antiparkinson therapy was interrupted, and 20 mg prodipin was infused. In group 2 and 3 the therapy was continued, while an additional 20 mg of prodipin was administered by infusion only to group 3. 4 Liquor-samples were obtained from each patient: 1 basic value and three additional samples 5, 8 and 24 hours after administration of 2 g probenecid. The base concentration of HVA was 15 ng/ml and this was not increased by probenecid in group 1; the concentration of 5-HIAA was 11.6 ng/ml and this was doubled by probenecid to 22.9 ng/ml. The HVA concentration increased to a maximum of 28.9 ng/ml during continued therapy (group 2); the elevated 5-HIAA remained unchanged. Prodipin does not cause an alteration in metabolite concentration in cases of interrupted therapy (group 1), but leads, in the case of continued therapy, to a 1.8-fold increase in HVA, and a 1.6-fold increase in 5-HIAA (group 3).
    Digital Access Access Options